Copyright © 2009 Domenico Mastrangelo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. Z. A. Karcioglu and T. Hadjistilianou, “Ocular tumors,” in Orbital Tumors: Diagnosis and Treatment, Z. A. Karcioglu, Ed., pp. 257–265, Springer, New York, NY, USA, 2004.
2. C. L. Shields, A. T. Meadows, A. M. Leahey, and J. A. Shields, “Continuing challenges in the management of retinoblastoma with chemotherapy,” Retina, vol. 24, no. 6, pp. 849–862, 2004. View at Publisher · View at Google Scholar
3. C. L. Shields and J. A. Shields, “Basic understanding of current classification and management of retinoblastoma,” Current Opinion in Ophthalmology, vol. 17, no. 3, pp. 228–234, 2006. View at Publisher · View at Google Scholar · View at PubMed
4. D. Mastrangelo, S. De Francesco, A. Di Leonardo, L. Lentini, and T. Hadjistilianou, “Retinoblastoma epidemiology: does the evidence matter?” European Journal of Cancer, vol. 43, no. 10, pp. 1596–1603, 2007. View at Publisher · View at Google Scholar · View at PubMed
5. D. Mastrangelo, S. De Francesco, A. Di Leonardo, L. Lentini, and T. Hadjistilianou, “Does the evidence matter in medicine? The retinoblastoma paradigm,” International Journal of Cancer, vol. 121, no. 11, pp. 2501–2505, 2007. View at Publisher · View at Google Scholar · View at PubMed
6. A. G. Knudson Jr., “Mutation and cancer: statistical study of retinoblastoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 4, pp. 820–823, 1971.
7. A. G. Knudson Jr., “Heredity and human cancer,” American Journal of Pathology, vol. 77, no. 1, pp. 77–84, 1974.
8. A. G. Knudson Jr., “The genetics of childhood cancer,” Cancer, vol. 3, supplement, pp. 1022–1026, 1975.
9. A. G. Knudson Jr., “Genetics of human cancer,” Genetics, vol. 79, supplement, pp. 305–316, 1975.
10. A. G. Knudson Jr., “Mutation and childhood cancer: a probabilistic model for the incidence of Rb,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 12, pp. 5116–5120, 1975.
11. A. G. Knudson Jr., “Mutation and cancer in man,” Cancer, vol. 39, no. 4, supplement, pp. 1882–1886, 1977.
12. A. G. Knudson Jr., “Model for the incidence of embryonal cancers: application to Rb,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 5, pp. 2453–2457, 1978.
13. A. G. Knudson Jr., “Hereditary cancer,” The Journal of the American Medical Association, vol. 241, no. 3, p. 279, 1979.
14. A. G. Knudson Jr., “Persons at high risk of cancer,” The New England Journal of Medicine, vol. 301, no. 11, pp. 606–607, 1979.
15. A. G. Knudson Jr., “Genetics and cancer,” The American Journal of Medicine, vol. 69, no. 1, pp. 1–3, 1980.
16. A. G. Knudson Jr., “Hereditary cancer, oncogenes, and antioncogenes,” Cancer Research, vol. 45, no. 4, pp. 1437–1443, 1985.
17. A. G. Knudson Jr., “Hereditary cancers disclose a class of cancer genes,” Cancer, vol. 63, no. 10, pp. 1888–1891, 1989.
18. A. G. Knudson Jr., “Antioncogenes and human cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 10914–10921, 1993.
19. A. G. Knudson Jr., “Hereditary cancers: from discovery to intervention,” Journal of the National Cancer Institute, vol. 17, pp. 5–7, 1995.
20. A. G. Knudson Jr., “Hereditary cancer: two hits revisited,” Journal of Cancer Research and Clinical Oncology, vol. 122, no. 3, pp. 135–140, 1996. View at Publisher · View at Google Scholar
21. A. G. Knudson Jr., “Cancer genetics,” American Journal of Medical Genetics, vol. 111, no. 1, pp. 96–102, 2002. View at Publisher · View at Google Scholar · View at PubMed
22. A. G. Knudson Jr., “Cancer genetics through a personal retrospectroscope,” Genes Chromosomes and Cancer, vol. 38, no. 4, pp. 288–291, 2003. View at Publisher · View at Google Scholar · View at PubMed
23. A. G. Knudson Jr., “Of sea urchins and worms: development and cancer,” Cell Death and Differentiation, vol. 11, no. 1, pp. 11–12, 2004. View at Publisher · View at Google Scholar · View at PubMed
24. A. G. Knudson Jr., “A personal sixty-year tour of genetics and medicine,” Annual Review of Genomics and Human Genetics, vol. 6, pp. 1–14, 2005. View at Publisher · View at Google Scholar · View at PubMed
25. D. Rushlow, B. Piovesan, K. Zhang, et al., “Detection of mosaic RB1 mutations in families with retinoblastoma,” Human Mutation, vol. 30, no. 5, pp. 842–851, 2009. View at Publisher · View at Google Scholar · View at PubMed
26. http://www.geneclinics.org/profiles/retinoblastoma/details.html.
27. V. R. Potluri, L. Helson, R. M. Ellsworth, T. Reid, and F. Gilbert, “Chromosomal abnormalities in human retinoblastoma. A review,” Cancer, vol. 58, no. 3, pp. 663–671, 1986.
28. F. Munier, G. Pescia, M. Jotterand-Bellomo, A. Balmer, C. Gailloud, and F. Thonney, “Constitutional karyotype in retinoblastoma. Case report and review of literature,” Ophthalmic Paediatrics and Genetics, vol. 10, no. 2, pp. 129–150, 1989.
29. T. Zenz, H. Döhner, and S. Stilgenbauer, “Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia,” Best Practice and Research: Clinical Haematology, vol. 20, no. 3, pp. 439–453, 2007. View at Publisher · View at Google Scholar · View at PubMed
30. A. D. Panani, “Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications,” Cancer Letters, vol. 255, no. 1, pp. 12–25, 2007. View at Publisher · View at Google Scholar · View at PubMed
31. P. Liebisch and H. Döhner, “Cytogenetics and molecular cytogenetics in multiple myeloma,” European Journal of Cancer, vol. 42, no. 11, pp. 1520–1529, 2006. View at Publisher · View at Google Scholar · View at PubMed
32. N. Nishida, T. Nishimura, T. Ito, T. Komeda, Y. Fukuda, and K. Nakao, “Chromosomal instability and human hepatocarcinogenesis,” Histology and Histopathology, vol. 18, no. 3, pp. 897–909, 2003.
33. J. Y. Shao, W. F. Zeng, and Y. X. Zeng, “Molecular genetic progression on nasopharyngeal carcinoma,” Ai Zheng, vol. 21, no. 1, pp. 1–10, 2002.
34. A. Dahlén, M. Debiec-Rychter, F. Pedeutour, et al., “Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors,” International Journal of Cancer, vol. 103, no. 5, pp. 616–623, 2003. View at Publisher · View at Google Scholar · View at PubMed
35. C. Léonard, J.-L. Huret, and Groupe français de cytogénétique oncologique, “From cytogenetics to cytogenomics of bladder cancers,” Bulletin du Cancer, vol. 89, no. 2, pp. 166–173, 2002.
36. A. De Rienzo and J. R. Testa, “Recent advances in the molecular analysis of human malignant mesothelioma,” Clinica Terapeutica, vol. 151, no. 6, pp. 433–438, 2000.
37. G. Sauter, L. Bubendorf, H. Moch, Th. C. Gasser, and M. J. Mihatsch, “Cytogenetic alterations in prostatic carcinoma,” Pathologe, vol. 19, no. 1, pp. 63–68, 1998. View at Publisher · View at Google Scholar
38. http://www.genecards.org/cgi-bin/carddisp.pl?gene=Rb1.
39. D. Mastrangelo, S. De Francesco, A. Di Leonardo, L. Lentini, and T. Hadjistilianou, “The retinoblastoma paradigm revisited,” Medical Science Monitor, vol. 14, no. 12, pp. 231–240, 2008.
40. A. C. Schefler and D. H. Abramson, “Retinoblastoma: what is new in 2007-2008,” Current Opinion in Ophthalmology, vol. 19, no. 6, pp. 526–534, 2008. View at Publisher · View at Google Scholar · View at PubMed